Actively Recruiting
Comparative Efficacy of Magnesium Supplement and Melatonin Congener in Young Adults With Primary Insomnia
Led by CMH Kharian Medical College · Updated on 2025-05-30
60
Participants Needed
1
Research Sites
8 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Sleep is essential for overall health and well-being, influencing many body functions. Researchers are studying the effectiveness of magnesium supplements compared to melatonin congeners in young adults who have primary insomnia. Unlike most insomnia studies focusing on older adults or those with other health issues, this trial targets healthy young adults aged 18 to 40 to provide age-specific insights. Participants will be randomly assigned to one of two groups for a 4-week treatment period. One group will take oral magnesium glycinate tablets at a dose of 500 mg nightly, while the other group will take oral melatonin tablets at 10 mg nightly. Both treatments are given as tablets and taken once each night. During the study, participants will be monitored for changes in their insomnia severity using the Insomnia Severity Index over the 4 weeks. Researchers will evaluate sleep difficulties and related daytime impairments. Participants will be assessed at regular intervals to track the effectiveness and impact of the supplements on their sleep patterns.
CONDITIONS
Brief Title
Comparative Efficacy of Magnesium Supplement and Melatonin Congener in Young Adults With Primary Insomnia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18-40 years
- Male and female participants who are not pregnant or breastfeeding
- Diagnosed with primary insomnia characterized by difficulty falling asleep, staying asleep, or nonrestorative sleep
- Sleep difficulty occurs at least 3 times per week and has lasted for at least 1 month
- Sleep impairment causes daytime distress or problems
- Adequate opportunity and environment for sleep present
You will not qualify if you...
- Insomnia caused by a known underlying medical condition
- Having any psychiatric illness
- Currently using sedative hypnotic medications
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 4 weeks
Participants receive either magnesium supplements or melatonin tablets nightly to treat primary insomnia.
1 baseline visit and weekly visits during treatment
Trial Site Locations
Total: 1 location
1
CMH Kharian Medical College
Kharan, Punjab Province, Pakistan, 50070
Actively Recruiting
Research Team
M
Mushayada Irshad, MBBS, MPhil Pharmacology
U
Usman Nawaz, MBBS, MPhil, PhD Pharmacology
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here